Identification of clinically actionable pharmacogenetic variants during tumor genetic profiling in pediatric cancer patients

被引：2
|
作者：
Hertz, Daniel Louis
Robinson, Dan R.
Lonigro, Robert J.
Wu, Yi-Mi
Vats, Pankaj
Cao, Xuhong
Nobani, Andrew
Mora, Erika
Chinnaiyan, Arul M.
Mody, Rajen
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigain Hlth Syst, Ann Arbor, MI USA
[3] Univ Michigan, Ctr Translat Pathol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1583
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical Implementation of the NextDaySeq Lung Panel for Identification of Clinically Actionable Variants in Non-Small Cell Lung Cancer
    Gao, Jie
    Wu, Huanwen
    Shi, Xiaohua
    Huo, Zhen
    Zhang, Jing
    Liang, Zhiyong
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S232 - S232
  • [32] Molecular tumor profiling identifies actionable targets in patients with cholangiocarcinoma
    Avogadri-Connors, Francesca
    Wei, Ge
    Dambkowski, Carl L.
    Li, Gary
    Soifer, Harris S.
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Identification of putative actionable alterations in clinically relevant genes in breast cancer
    Pushpinder Kaur
    Tania B. Porras
    Anthony Colombo
    Alexander Ring
    Janice Lu
    Irene Kang
    Julie E. Lang
    British Journal of Cancer, 2021, 125 : 1270 - 1284
  • [34] Identification of putative actionable alterations in clinically relevant genes in breast cancer
    Kaur, Pushpinder
    Porras, Tania B.
    Colombo, Anthony
    Ring, Alexander
    Lu, Janice
    Kang, Irene
    Lang, Julie E.
    BRITISH JOURNAL OF CANCER, 2021, 125 (09) : 1270 - 1284
  • [35] Insights into clinically actionable biomarkers in an Indian cancer cohort of 1000 patients using comprehensive genomic profiling (CGP)
    Ghosh, M.
    Balaram, G.
    Lingaraju, S. M.
    Raghavendrachar, K.
    Kodandapani, R.
    Erappareddy, V.
    Keriyappa, V.
    Ghorpade, S. N.
    Patil, S.
    Thungappa, S. Chiradoni
    Bhattacharjee, S.
    Susheela, S. Papaiah
    Naseer, M. R.
    Dasgupta, R.
    Jayappa, S. Belagutti
    Ramaswamy, V.
    Hattangdi, D.
    Ravichandran, A.
    Bahadur, U.
    Ajaikumar, B. S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1628 - S1628
  • [36] Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing
    van der Wouden, Cathelijne H.
    van Rhenen, Mandy H.
    Jama, Wafa O. M.
    Ingelman-Sundberg, Magnus
    Lauschke, Volker M.
    Konta, Lidija
    Schwab, Matthias
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (04) : 866 - 873
  • [37] High-Throughput Diagnostic Profiling of Clinically Actionable Gene Fusions in Lung Cancer
    Pfarr, Nicole
    Stenzinger, Albrecht
    Penzel, Roland
    Warth, Arne
    Dienemann, Hendrik
    Schirmacher, Peter
    Weichert, Wilko
    Endris, Volker
    GENES CHROMOSOMES & CANCER, 2016, 55 (01): : 30 - 44
  • [38] Prevalence of clinically actionable germline pathogenic variants (PVs) in advanced prostate cancer (aPC)
    Hahn, A. W.
    Kapron, A. L.
    Boyle, J.
    Kohlmann, W.
    Poole, A.
    Gill, D. M.
    Greenberg, S.
    Hale, P.
    Teerlink, C.
    Maughan, B. L.
    Cannon-Albright, L.
    Agarwal, N.
    Cooney, K. A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] Multigene profiling to identify clinically relevant actionable mutations in breast cancer: An Indian study
    Ghosh, M.
    Sheela, M. L.
    Choudhury, S.
    Bahadur, U.
    Patil, S.
    Satheesh, C. T.
    Murugan, K.
    Nayak, R.
    Sridhar, P. S.
    Rao, N.
    Mahesh, B.
    Shashidhara, H. P.
    Krishnamoorthy, N.
    Gupta, V.
    Sankaran, S.
    Subramanian, K.
    Ajaikumar, B. S.
    CANCER RESEARCH, 2016, 76
  • [40] Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs
    Koo, Hyunwoo
    Smith, Tayler B.
    Callaghan, John T.
    Osei, Wilberforce
    Bray, Steven M.
    Tillman, Emma M.
    Tran, Mya T.
    Fausel, Christopher A.
    Schneider, Bryan P.
    Shugg, Tyler
    Skaar, Todd C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
12345